PSCA, His, Mouse
PSCA, His, Mouse

The purity of PSCA, His, Mouse is greater than 95% as determined by SEC-HPLC.

PSCA, His, Mouse

PSCA, His, Mouse on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

PSCA, His, Mouse

Gastric cancer is a deadly malignancy and is a prognostically unfavorable entity with restricted therapeutic strategies available. Prostate stem cell antigen (PSCA) is a glycosylphosphatidylinositol (GPI)-anchored cell surface protein widely expressed in bladder, prostate, and pancreatic cancers. Existing studies have thoroughly recognized the availability of utilizing anti-PSCA CAR-T cells in the treatment of metastatic prostate cancer and non-small-cell lung cancer.
Z06324
¥48,501.00

Ask us a question
Product Introduction
Species Mouse
Protein Construction
His PSCA (Leu21-Asn95)_x000D_
Accession # P57096
N-term C-term
Purity > 95% as determined by Bis­Tris PAGE 
> 95% as determined by HPLC
Endotoxin Level Less than 1EU per μg by the LAL method.
Expression System HEK293
Theoretical Molecular Weight 9.8 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 20-30 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles.

Examples
  • PSCA, His, Mouse
    • PSCA, His, Mouse

    The purity of PSCA, His, Mouse is greater than 95% as determined by SEC-HPLC.

  • PSCA, His, Mouse
    • PSCA, His, Mouse

    PSCA, His, Mouse on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.


Background
Target Background Gastric cancer is a deadly malignancy and is a prognostically unfavorable entity with restricted therapeutic strategies available. Prostate stem cell antigen (PSCA) is a glycosylphosphatidylinositol (GPI)-anchored cell surface protein widely expressed in bladder, prostate, and pancreatic cancers. Existing studies have thoroughly recognized the availability of utilizing anti-PSCA CAR-T cells in the treatment of metastatic prostate cancer and non-small-cell lung cancer.
Synonyms PSCA; UNQ206; PRO232

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.